Adam Havey is an accomplished executive with extensive experience in the pharmaceutical and healthcare industries. Currently serving as Chief Operating Officer at Niowave, Inc., Adam is responsible for overseeing the production of medical radioisotopes and the operation of superconducting electron accelerators while ensuring regulatory compliance. Prior to this role, Adam held various senior positions at Emergent BioSolutions, including Executive Vice President and Chief Operating Officer, where responsibilities encompassed commercial operations, public health initiatives, and diverse business units. Adam's earlier career includes key roles at Eli Lilly, ProModel Corporation/QuestOne, and International Paper, where leadership in project management and manufacturing processes was demonstrated. Adam earned a Bachelor of Science in Chemical Engineering from Michigan State University.